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ABSTRACT 
Bock, C. H., Gottwald, T. R., Parker, P. E., Ferrandino, F., Welham, S., 
van den Bosch, F., and Parnell, S. 2010. Some consequences of using the 
Horsfall-Barratt scale for hypothesis testing. Phytopathology 100:1030-
1041. 
Comparing treatment effects by hypothesis testing is a common 
practice in plant pathology. Nearest percent estimates (NPEs) of disease 
severity were compared with Horsfall-Barratt (H-B) scale data to explore 
whether there was an effect of assessment method on hypothesis testing. 
A simulation model based on field-collected data using leaves with 
disease severity of 0 to 60% was used; the relationship between NPEs and 
actual severity was linear, a hyperbolic function described the relationship 
between the standard deviation of the rater mean NPE and actual disease, 
and a lognormal distribution was assumed to describe the frequency of 
NPEs of specific actual disease severities by raters. Results of the 
simulation showed standard deviations of mean NPEs were consistently 
similar to the original rater standard deviation from the field-collected 
data; however, the standard deviations of the H-B scale data deviated 
from that of the original rater standard deviation, particularly at 20 to 
50% severity, over which H-B scale grade intervals are widest; thus, it is 
over this range that differences in hypothesis testing are most likely to 
occur. To explore this, two normally distributed, hypothetical severity 
populations were compared using a t test with NPEs and H-B midpoint 
data. NPE data had a higher probability to reject the null hypothesis (H0) 
when H0 was false but greater sample size increased the probability to 
reject H0 for both methods, with the H-B scale data requiring up to a 50% 
greater sample size to attain the same probability to reject the H0 as NPEs 
when H0 was false. The increase in sample size resolves the increased 
sample variance caused by inaccurate individual estimates due to H-B 
scale midpoint scaling. As expected, various population characteristics 
influenced the probability to reject H0, including the difference between 
the two severity distribution means, their variability, and the ability of the 
raters. Inaccurate raters showed a similar probability to reject H0 when H0 
was false using either assessment method but average and accurate raters 
had a greater probability to reject H0 when H0 was false using NPEs 
compared with H-B scale data. Accurate raters had, on average, better 
resolving power for estimating disease compared with that offered by the 
H-B scale and, therefore, the resulting sample variability was more 
representative of the population when sample size was limiting. Thus, 
there are various circumstances under which H-B scale data has a greater 
risk of failing to reject H0 when H0 is false (a type II error) compared with 
NPEs. 
 
Plant disease severity—the proportion of a plant unit diseased 
(31)—can be assessed in various ways. There are several kinds of 
disease assessment scales that have been developed to help 
estimate the amount of disease on a leaf or plant or in a plot or 
field (2,7,23). One of the most widely used scales in plant disease 
assessment is the Horsfall-Barratt (H-B) scale (15) and its 
plethora of offspring; however, its characteristics and the ramifi-
cations of using the scale have only recently begun to be explored 
(2,10,12,25,26). 
The H-B scale (15) divides the percent scale into 12 logarith-
mic-based severity intervals between 0 and 100%. The interval 
sizes are symmetrical either side of 50% (Table 1), with the 
symmetry being based on the (apparently unproven) observation 
that the eye reads diseased tissue at <50% disease and healthy 
tissue at >50% disease (15). 
Disease severity assessments are often made using the H-B 
scale. The original article (15) has been cited at least 561 times 
(39), and Current Contents (14) interviewed Horsfall on the 
original Horsfall and Barratt article (15) under the “Citation 
Classics” feature. Originally, Horsfall and Barratt (15) and 
Horsfall (13) recommended averaging the grade values prior to 
using a calibration curve to read actual disease on the y-axis (a 
process that removed heterogeneity of variance, because each 
grade is given equal weight) but this resulted in bias (34). Thus, 
the requirement to convert each grade measurement back to a 
percentage (thereby reasserting heterogeneity of variance) was 
necessary. The process for converting the H-B scale estimates into 
a mean severity is as follows: first, the appropriate grade on the 
scale is allotted to each individual in a sample of leaves or plants 
(15); second, for each grade, the percent range midpoint is taken 
directly or using the Elanco conversions (34); and third, the 
percent midpoints for all individuals in the sample are summed 
and averaged (sum of midpoint percents/sample size) to arrive at 
the estimated mean percent disease severity. 
The use of the H-B-scale has been the subject of controversy 
for almost as long as it has been around (1,2,7,9–12,18,25,26). 
The interpretation that the scale described an apparent logarithmic 
relationship between estimated and actual disease severity has 
now been shown not to be the case (3,5,12,25,26,29). A linear 
relationship exists between estimated disease and actual disease. 
However, the nature of the relationship between the variance (or 
standard deviation, or estimation error) and the magnitude of the 
actual value has not been fully established. Nonconstancy of 
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variance with magnitude of actual disease is widely reported (2,4, 
9–11) and individuals vary greatly in their ability to assess dis-
ease; therefore inter- and intra-rater reliability is a further source 
of error in assessments (2,3,11,25,29). Furthermore, Hau et al. 
(11) demonstrated that characteristics of the distribution of dis-
eased leaves in the population and the number of classes in a 
disease scale affected the accuracy of the estimate of mean 
disease severity. Very skewed populations rated using a scale with 
few grades (<7) resulted in inaccurate mean estimates, although 
they did not compare these interval-scale estimates to nearest 
percent estimates (NPEs) or investigate the effects of sample size. 
There is also evidence that estimates of disease severity based on 
the H-B scale are most often less precise (sensu Madden et al. for 
measurement agreement [23]) compared with NPEs (2,25). 
Testing for treatment differences is a standard procedure in 
plant pathology. In many cases, two treatments (e.g., disease 
control options) are applied to plants in different plots, the 
severity of the disease subsequently estimated, and the resulting 
data sets analyzed. The statistical analysis often aims at testing 
the null hypothesis (H0) that the mean disease severities in the two 
treatments are equal. Rejecting the H0 is then used as indication 
that the two treatments actually have different effects on the 
severity of disease or the development of the epidemic (6,8,24, 
32,33). A standard way to test for differences in mean disease 
severity on a continuous scale such as percent disease severity is 
by using a t test (37). In the case of data generated using the H-B 
scale, the test uses the percent range midpoints of the grade 
assigned to each observation in the two data sets. Alternatively, 
using the grade numbers, a nonparametric test, of which the 
Mann-Whitney U test is an example, could be used to compare 
medians of the treatments. The Mann-Whitney U test is suffici-
ently analogous to the t test to serve as a comparison and does not 
require the assumption of continuous data. 
It has not been demonstrated how the use of the H-B scale 
affects hypothesis testing. Exploring the effects of H-B scaled 
data on hypothesis testing is the main objective of this study. Is 
use of the H-B scale less or more likely to (correctly) reject the H0 
when there actually is a difference between the mean severities in 
the two treatments, compared with NPEs of disease severity? 
NPEs of disease severity are notoriously variable (5,25,28), 
reducing the probability to reject the H0 when there actually is a 
difference between the mean severities in the two treatments (32). 
On the other hand, using the H-B scale and midpoint values might 
introduce additional variability into the samples (2,10,25). The 
effect of H-B scaled data on the probability to reject H0 when H0 
is false has not been explored. 
To explore the effects of using the H-B scale on hypothesis 
testing, we developed a generalized rater estimation distribution, 
based on a previous data set (3,4). We used this model in a 
simulation study to sample from two hypothetical disease severity 
distributions, using both the H-B scale and NPEs. The samples 
from the disease severity distributions were analyzed using the t 
test (NPE and H-B midpoint data) and the Mann-Whitney U test 
(grade data) to compare the probability to reject H0. 
THEORY AND APPROACHES 
Actual and estimated disease severity. The data described by 
Bock et al. (3,4) were used to develop a model that describes a 
generalized rater ability to estimate disease at different severities 
of 0 to 60%. The original data were based on a sample of 210 
citrus canker (Xanthomonas citri subsp. citri)-infected grapefruit 
leaves and encompass (i) measurements of the “actual” disease 
severity on a leaf-by-leaf basis using image analysis (ASSESS; 
American Phytopathological Society, St. Paul, MN) and (ii) rater 
NPEs of disease severities for each of the 200 leaves on two 
separate occasions. 
Combining the NPEs of the three raters from two separate 
assessment occasions was assumed to provide an adequate 
description of generalized distribution characteristics of estimates 
of specific actual disease severities over that disease range. 
To achieve sufficient data to estimate the mean and standard 
deviation at different actual disease severities, the data were 
grouped in actual severity intervals of 0 to 1, 1+ to 2, 2+ to 3, 3+ to 
5, 5+ to 7.5, 7.5+ to 10, 10+ to 15, 15+ to 20, 20+ to 30, 30+ to 40, 
and 40+ to 60% disease. To describe the mean rater estimated 
severity, µrater, as a function of the actual severity, µactual, a linear 
model was used:  
µrater = θµactual (1) 
where θ is a constant. To describe the relationship between the 
actual disease severity, µactual, and the standard deviation (σ) of the 
severity estimates, a hyperbolic model was fit to the data: 
σ = (αµactual)/(β + µactual)   (2) 
where α and β are parameters.
 
Rater distribution of severity estimates. The distribution of 
the severity estimates was described by incorporating both the 
linear relationship between estimated and actual severity (equa-
tion 1) and the hyperbolic function for the standard deviation of 
the estimate as a function of the actual severity (equation 2). We 
assume that the severity as assessed by a generalized rater based 
on the combined rater data (at a given actual mean severity) is 
log-normally distributed: 
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and where ρ is the standard deviation of the mean estimates 
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Disease severity distributions and the effect of treatments. If 
two treatments are applied to a developing epidemic, treatment A 
TABLE 1. Horsfall-Barratt (H-B) scale (15) showing the grades, ranges for
the grades, H-B midpoints, and ELANCO midpoints (34) 
H-B gradea Range Size of interval Midpoint (ELANCO) 
1 0 0 0 (0) 
2 0+–3 3 1.5 (2.34) 
3 3+–6 3 4.5 (4.69) 
4 6+–12 6 9.0 (9.38) 
5 12+–25 13 18.5 (18.75) 
6 25+–50 25 37.5 (37.50) 
7 50+–75 25 62.5 (62.50) 
8 75+–87 13 81.5 (81.25) 
9 87+–94 6 91.0 (90.62) 
10 94+–97 3 96.5 (95.31) 
11 97+–100 3 98.5 (97.66) 
12 100 0 100.0 (100) 
a Horsfall and Barratt numbered the scale in two different ways, depending on
which citation is referred to in the literature. In Horsfall and Barratt (15) it is
described as a 1-to-12 scale (where 1 = 0) but, in Horsfall (13) and Horsfall
and Cowling (16), the calibration curves show a 0-to-11 scale (where 0 = 0).
Redman et al. (34) use a 0-to-11 scale. This is pointed out as a potential
source of confusion as each grade will be shifted by “1” depending on the
applied scale. 
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and treatment B, then, at time t, the epidemics have developed a 
particular leaf severity population distribution for each treatment 
(Fig. 1) which we assumed to be normal distributions. The disease 
severity distribution of treatment A has mean µA and treatment B 
has mean µB = µA + µΔ, where µΔ represents the difference be-
tween the means of the two severity distributions and, thus, re-
flects the treatment difference. Then, µΔ = 0 implies that the 
treatments did not result in any effect and, therefore, the mean 
disease severities are the same; µΔ > 0 or < 0 implies that the 
treatment affected the epidemic such that a difference in mean 
severity developed. Without loss of generality, we only considered 
µΔ > 0. The two hypothetical populations of diseased leaves, A 
and B, are assumed to have an equal standard deviation (ϕ). 
Sampling. To simulate disease severity estimation to the 
nearest percent by raters, n samples were taken randomly from 
each of the two disease severity distributions, A and B. These are 
the actual severities of the 2n samples. Next, we determined the 
rater observed severity for each of these actual severities. This 
was achieved for each of the 2n samples separately by drawing 
from the log-normal distribution with the actual severity as the 
mean of the distribution, µactual. This gives the rater-observed 
severities for the n samples from each of the distributions. 
To simulate observations using the H-B scale, the data derived 
above were converted to the appropriate grade on the H-B scale (1 
to 12) and grade numbers used for the nonparametric analysis 
(Mann-Whitney U test). These grade data were subsequently 
converted to the appropriate midpoint value for that grade for 
analysis with the parametric test (t test). Thus, three sets of data 
were generated from the simulated assessment process that 
mimics NPE and H-B scale assessments, as follows: (i) n 
observations from the disease severity distribution with treatment 
A and n observations from treatment B, mimicking NPEs of 
disease severity by direct observation of the symptoms by a rater; 
(ii) n observations from the disease severity distribution with 
treatment A and n observations from treatment B, mimicking the 
use of the H-B scale; and (iii) n observations from the disease 
severity distribution with treatment A and n observations from 
treatment B using the H-B scale and subsequently converting the 
grade number to the midpoint severity of that interval range. 
Testing. Each of the three sets of data was tested with the aim 
of detecting differences in the mean severity of the severity 
distributions resulting from the two treatments (A and B). For 
data set (i) and (iii), we used the two-sample t test, with the H0 
being that the means of the two samples are equal. For data set 
(ii), we used the Mann-Whitney U test. The H0 of this test was 
that the samples were drawn from the same distribution. The 
threshold for the rejection of H0 was set at P = 0.05. The choice of 
a P value of 0.05 was arbitrary; there are advantages and 
disadvantages to increasing strength (i.e., 0.1, 0.05, or 0.01) but, 
here, we were concerned only with the relative difference be-
tween the two methods (NPE and H-B) and not with the strength 
of the test (i.e., we were not trying to disprove an H0). Further-
more, by convention, P = 0.05 is the most widely used P value. 
Thus, the output variable was the probability to reject the H0, and 
the aim was to investigate whether this probability was influenced 
by the way the observations were obtained (i.e., by NPEs or by 
using the H-B scale). To calculate the probability that the H0 is 
rejected, the procedure outlined above was repeated 10,000 times 
unless stated otherwise and the t or Mann-Whitney U test 
performed each time. The proportion of occasions that the H0 was 
rejected in these 10,000 tests was plotted against various param-
eters (P value, magnitude of severity population mean, difference 
between severity population means, magnitude of severity 
population standard deviation, sample size, and rater ability). 
RESULTS 
Characteristics of the real and simulated data. The mean 
severity calculated from the three rater estimates showed a linear 
relationship with the actual disease severity (Fig. 2B). Because 
the estimated parameter, θ in equation 1, was not significantly 
different from unity (P < 0.001), we have used θ = 1. This value 
implies that the average rater-observed severity equals the actual 
severity (Fig. 2B), although a tendency to overestimate disease at 
actual severities <10% is common (4,35). The linear relationship 
is in agreement with other studies (3,25,29). That θ = 1 shows that 
the rater has no systematic bias toward over- or underestimation 
(i.e., the rater mean is an accurate estimate of the actual mean). 
The hyperbolic function described the relationship between the 
standard deviation of the rater mean NPEs and the actual mean 
disease severity accurately (Fig. 2C). Thus, the standard deviation 
of the rater mean NPEs increased almost linearly with actual 
severity at low actual severity but, for larger actual severity, the 
slope of the relationship decreased with increasing actual severity. 
Other studies have found that the standard deviation of the mean 
severity initially increases but that rate of increase declines 
between 12 and 25% mean disease severity (9,11). 
Based on the lognormal distribution of generalized rater ability 
and the parameters described in the previous section, 10,000 
NPEs were taken from 0 to 50% severity in 1% increments (Fig. 
 
Fig. 1. Example of the hypothetical population distributions used to test nearest percent estimates (NPE) and the Horsfall-Barratt (H-B) scale for detecting 
differences. We were interested in knowing whether a random sample taken from each can detect the difference in the two distributions when NPEs are used, and 
when these are converted to H-B midpoint values. The parameters are the ones referred to in Figures 4 to 8. The null hypothesis (H0) is that the two distributions 
(A, µA and B, µB) are the same (which occurs when and µΔ = 0, standard deviation (ϕ) of µA = µB for all plots). 
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3A). The standard deviation of the mean of various sample sizes 
is generally in close agreement with the actual rater standard 
deviations (Fig. 3B). Only if sample size was particularly small 
(for example, two observations) was the standard deviation  
low throughout the range of actual disease simulated in this study 
(0 to 50% area infected). The underestimation of the standard 
deviation with small sample size is due to diminished outlier 
effects. 
If these estimates are converted to the H-B midpoint values 
(Fig. 3C), the standard deviation clearly has characteristics differ-
ent from those calculated from the NPEs (Fig. 3D). The standard 
deviation tends to be larger or smaller when using the H-B scale 
for all sample sizes. Only at low actual disease severity (<20%) 
where interval ranges are small is the standard deviation close to 
the rater standard deviation. Sample sizes ≥5 tended to have larger 
standard deviations compared with the rater standard deviation, 
 
Fig. 2. A, Estimated disease severity data by three raters on two occasions assessing each of 200 grapefruit leaves infected with citrus canker (95% confidence 
limits are shown). B, Relationship between the mean estimated severity and the actual severity (µrater = θactual, r2 = 0.96). C, Relationship between the standard 
deviations of the estimated means and the actual severity (hyperbolic fit, σ = αµactual/β + µactual, parameters α = 19.08, standard deviation (s.d.) = 3.19; β = 29.65, 
s.d. = 9.334, r2 = 0.95). 
1034 PHYTOPATHOLOGY 
except in the region of the midpoint of the largest interval size 
(midpoint value 37.5%), where a dip occurred and most groups 
had a smaller standard deviation. Similar to the standard deviation 
from the NPEs, only sample sizes of n = 2 had consistently 
smaller standard deviation throughout the range 0 to 50% area 
infected. 
From these results, showing the effect of NPEs and the H-B 
scaled data on the estimated standard deviation of the mean 
estimate, the ability of these two different data to differentiate 
means is most likely different at severities of 20 to 50+%. The 
information that has been published on the frequency of different 
severities on individual leaves suggests that these disease 
severities are common in many pathosystems in the field (11,21). 
Therefore, this range of severities was used to illustrate the 
differences in hypothesis testing between the two assessment 
methods. 
Hypothesis testing. Probability level. As expected, a larger P 
value increased the probability to reject H0 when this hypothesis 
was false (Fig. 4). Although the trends were similar for both NPEs 
and H-B scaled data, NPEs of disease severity invariably had a 
greater probability to correctly reject the H0 compared with H-B 
scaled data. At a given P value, larger sample sizes increased the 
probability to reject H0 when H0 was false with both NPEs and H-
B scaled data; however, with small sample sizes, NPEs have a 
greater probability to reject H0 (when H0 is false). Particularly at 
small sample sizes, the nonparametric Mann-Whitney U test re-
sulted in the lowest probability compared with the t test. At 
sample sizes of ≥50, the two tests had equal probabilities and the 
superiority of NPEs was marginal. 
When populations are identical (i.e., no treatment difference). 
When the severity distributions of the two treatments are the 
same, meaning µΔ = 0 (Fig. 5A to D), the t test rejects the H0 
 
Fig. 3. A, Results of 1,000 simulations per percent severity of 1 to 50% showing the distribution of estimates of actual disease based on the lognormal distribution
of rater ability described in the Materials and Methods. In all, 10,000 simulations were used to generate the results but only 1,000 are shown here for clarity of 
display. B, Data from A, but scaled to the Horsfall and Barratt scale. C, Means of the standard deviations of simulated nearest percent estimates parsed into groups 
of different sample sizes and D, means of the standard deviations of simulated Horsfall-Barratt scaled estimates parsed into groups of different sample sizes. 
Sample size is the number of observations on which the standard deviation of the mean was based. The bold black line is the hyperbolic fit to the actual standard 
deviation. 
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(being that µΔ = 0) although it is true (a type I error) in ≈5% of the 
cases. This closely agrees with the choice of a P value of 0.05. 
There is no effect of sample size on this probability. There seems 
to be no difference between the data generated using the H-B 
scale and the data generated by NPE observations. As noted, at 
lower severity (<20%), the standard deviations of the estimates of 
the two methods are in close agreement (Fig. 3) and, thus, the 
probability of rejecting H0 when the populations are the same and 
the mean severity low are similar, and close to 0.05, for both 
disease-assessment methods (data not shown). Applying the 
nonparametric Mann-Whitney U test to the H-B scale data 
resulted in a slightly smaller probability to reject the H0 when it is 
true for H-B scaled data at lower replication. 
Different population means and the effect of sample size. As is 
to be expected, increased sample size increased the probability to 
reject H0 (being that µΔ = 0) when this hypothesis is false (Fig. 6) 
(i.e., there is a difference in mean disease severity between the 
two treatments). This holds for both assessment methods and both 
tests applied; however, NPEs of disease severity have a greater 
probability to correctly reject the H0 compared with H-B scale 
data. Applying the nonparametric Mann-Whitney U test always 
resulted in the lowest probability to correctly reject the H0 when 
this hypothesis is false. 
The bold black lines in Figure 6A to D show the percent 
increase in the sample size using the H-B scale compared with 
NPEs needed to attain the same probability to reject the H0. In the 
most extreme cases, it is necessary to take 50% more samples 
when using the H-B scale to obtain the same probability to 
correctly reject the H0 compared with NPEs. 
Magnitude of the population difference and the effect of sample 
sizes. As expected, the greater the difference between the two 
severity distribution means, µΔ, the greater the probability to reject 
H0, a trend which holds for both assessment methods at all sample 
sizes tested (Fig. 7). As previously noted, larger sample sizes 
resulted in greater probability to reject H0 (when H0 was false). 
NPEs had a higher probability to reject H0 when H0 was false at 
small sample sizes although, with greater sample size, this effect 
was minimal. The trends were similar for both the parametric t 
test and nonparametric Mann-Whitney U test. 
The effect of the standard deviation of the severity distribution 
with different sample sizes. As might be expected, when the 
standard deviation (ϕ) of the severity distribution is large (vari-
able populations), there is a small probability to reject the H0 
when H0 is false using either NPEs or when the H-B scale is small 
(Fig. 8). Larger sample sizes increase the probability to reject H0 
when H0 is false; however, with smaller sample sizes, NPEs have 
a greater probability to reject H0, (when H0 is false), particularly 
when standard deviations are small, and was similar for both the 
parametric and nonparametric tests. 
The underlying population distribution affects the mean, 
median, and standard deviation of the mean, although the effect of 
using the H-B scale should be the same regardless of the 
distribution type. However, as population (and sample) variability 
increases (in wide or nonnormal distributions), the contribution of 
the H-B scale to sample variability will be relatively small 
compared with the amount of variability inherent in the sample—
hence, as the standard deviation increases, probability to reject H0 
(when H0 is false) declines and becomes similar for both methods 
of assessment (Fig. 8). 
Rater ability. The parameters in equation 2 relate to rater abil-
ity. The parameter α is the maximum standard deviation of the 
rater-observed disease severity. The ratio α/β is the slope of the 
relation between actual severity and the standard deviation of the 
rater’s observation for low disease severities. Thus, an inaccurate 
rater will have a large value for α as well as large value for α/β. 
An accurate rater will have a small value for α and α/β. 
“Accurate” is used here to describe the closeness of individual 
estimates to the actual disease severity on that leaf (31) and not 
 
Fig. 4. Effect of changing the P value (0.01 to 0.15) on the probability of 
rejecting the null hypothesis at various sample sizes (A, n = 10; B, n = 30; C,
n = 50) at mean disease severity of population A (µA = 40). Hypothesis test 
was performed on simulated nearest percent estimates and Horsfall-Barratt 
(H-B)  scaled data. Both data sets were analyzed using a t test and, in addition, 
the H-B scaled data were analyzed using the Mann-Whitney U test. Assumed 
fixed values were ϕ = 5 and µΔ = 10. 
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the accuracy of the mean value, which can be affected by rater 
bias. The accuracy of the individual estimates affects the variance 
of the mean. This study does not address error due to rater bias or 
bias in the mean value caused by the scale. 
Our results, based on 10,000 simulations each, show that, for a 
very inaccurate rater (Fig. 9A for larger values of α), there is little 
difference in the probability to reject H0 for NPEs or for H-B 
scaled data. The probability to reject H0 is small for an inaccurate 
rater, and our results show that such raters might equally well use 
the H-B scale or take NPEs. As a result, the standard deviations 
associated with NPEs by inaccurate raters (from α = 2 to 38 for 
2α/β) mostly exceed the standard deviations of the original mean 
rater estimates (Fig. 9D, shown by the bold black lines). 
At the other extreme (Fig. 9C), data gathered by very accurate 
raters almost always lead to the rejection of H0 (when H0 is false) 
when NPEs are used but using the H-B scale is detrimental to the 
probability to reject H0. This is reflected in the standard 
deviations of the NPEs (Fig. 9F), which are smaller (α/2β) than 
the original mean rater estimates standard deviation (α/β). 
Finally, average raters (Fig. 9B) with declining accuracy show 
similar trends but the ability to reject H0 when H0 is false is still 
higher for average raters using NPEs compared with the H-B 
scale, and the standard deviations of the estimates are closer to the 
standard deviations of the original mean rater estimates (Fig. 9E). 
DISCUSSION 
The generalized rater distribution. We developed a mathe-
matical description of the distribution of rater-estimated disease 
severities using the lognormal distribution. Bock et al. (4) used 
the normal distribution to describe the frequency of estimates 
compared with actual values but the lognormal distribution has 
the advantage that the tails do not tend to infinity, which is more 
realistic for estimation of a disease on the percent scale (0 to 
100%). The use of the log-normal distribution to characterize 
rater variability in severity estimation up to 50% severity is new. 
Other distributions, such as the logit-normal, might also yield 
appropriate descriptions of disease severity, especially at 50 to 
 
Fig. 5. Effect of sample size (n = 5–50) on the probability of rejecting the null hypothesis (H0) at various mean disease (µA, µB) severities (A, 20; B, 30; C, 40; and 
D, 50% disease severity) assuming no difference between the population means (µΔ = 0). Hypothesis test was performed on simulated nearest percent estimates 
and Horsfall-Barratt (H-B) scaled data. Both data sets were analyzed using a t test and, in addition, the H-B scaled data were analyzed using the Mann-Whitney U
test. Population fixed values were ϕ = 5, with a probability threshold of rejecting H0 of 0.05. 
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100% severity; although we don’t believe it will make a differ-
ence to the conclusions, it is something to consider in future 
work. 
The nonconstant relation between the actual disease severity 
and the standard deviation of the rater-estimated mean disease 
severity is implicit in several other studies (4,9–11,20). We 
described the relationship up to 50% actual disease as hyperbolic. 
Previous work suggests that standard deviation of the mean 
estimate is nonconstant with actual disease both with estimates of 
disease by the same individual (11) and by different individuals 
combined (5,9–11,20). For leaves with severity of 50 to 100%, the 
relationship was not characterized but the standard deviation will 
probably decline toward 100% severity. Other valid relationships 
will need to be developed when these characteristics have been 
established and, clearly, this is an area for future studies. 
In our data set based on the mean value of several ratings (Fig. 
2B), we found that the estimated mean severity equals the actual 
severity (determined using image analysis, θ = 1), confirming 
observations of a linear relationship found in other studies 
(3,5,11,25,26,28,29). Therefore, we have used a generalized rater 
distribution describing a nonbiased rater. Our method does allow 
for biased raters to be described, simply by taking θ ≠ 1. 
However, we considered rater bias (23) and its effect on 
hypothesis testing to be beyond the scope of this article. 
Interacting effects of population means, standard deviations 
and differences, the sample size, and rater ability on hy-
pothesis testing. When population mean differences were gross, 
disease severity distributions particularly variable, and sample 
sizes ample, there was little difference between NPEs or the H-B 
scale data from a generalized rater for hypothesis testing. Our 
results also show that, for populations where the mean disease 
severity was <20%, there was little or no difference between H-B 
scale estimates or NPEs. 
However, there are situations where using H-B scale-based data 
compared with using NPEs for hypothesis testing might result in 
a greater risk of failing to reject H0 when H0 is false, causing a 
type II error. This implies that, in these situations, NPEs would be 
preferred to using the H-B scale; however, our results also show  
 
Fig. 6. Effect of sample size (n = 5 to 50) on the probability of rejecting the null hypothesis (H0) at various mean disease (µA, µB) severities (A, 20; B, 30; C, 40; 
and D, 50% disease severity) assuming a difference between the population means (µΔ = 10). Hypothesis test was performed on simulated nearest percent
estimates and Horsfall-Barratt (H-B) scaled data. Both data sets were analyzed using a t test and, in addition, the H-B scaled data were analyzed using the Mann-
Whitney U test. Population fixed values were ϕ = 5, with a probability threshold of rejecting H0 of 0.05. The bold black line shows the required increase in sample 
size to get a probability of rejecting H0 with the H-B scaling equal to that of direct estimation at a given sample size. 
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Fig. 7. Effect of increasing difference between the population means (µΔ = 2 to 
20) on the probability of rejecting the null hypothesis (H0) at various sample
sizes (A, n = 10; B, n = 30; and C, n = 50) at mean disease severity of popu-
lation A (µA = 40). Hypothesis test was performed on simulated nearest 
percent estimates and Horsfall-Barratt (H-B) scaled data. Both data sets were
analyzed using a t test and, in addition, the H-B scaled data were analyzed
using the Mann-Whitney U test. Assumed fixed values were ϕ = 5, with a 
probability threshold of rejecting H0 of 0.05. 
 
Fig. 8. Effect of increasing disease severity population distribution standard 
deviation (ϕ = 2 to 20) on the probability of rejecting the null hypothesis (H0) 
at various sample sizes (A, n = 10; B, n = 30; and C, n = 50) at mean disease 
severity of population A (µA = 40). Hypothesis test was performed on simu-
lated nearest percent estimates and Horsfall-Barratt (H-B) scaled data. Both 
data sets were analyzed using a t test and, in addition, the H-B scaled data 
were analyzed using the Mann-Whitney U test. Assumed population differ-
ence (µA to µB) was fixed (µΔ = 10), with a probability threshold of rejecting 
H0 of 0.05. 
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that, if the H-B scale is used and it is possible to take up to a 50% 
larger sample compared with the NPE sample size, then both 
methods have a similar probability to reject H0 when H0 is false. 
These results confirm speculative discussion by Nutter and Esker 
(26) on the likelihood that added sample units are required to 
achieve a predetermined level of precision of the mean when 
using the H-B scale. 
Interacting with the mitigating effect of sample size, the factors 
that influence the probability of a type II error include the 
variability of the population (described by the standard deviation), 
 
Fig. 9. Effect of rater ability on the probability of rejecting the null hypothesis (H0) at three different parameter settings (A, 2α/β; B, α/β; and C, α/2β) for 
estimating rater standard deviation (s.d.). Hypothesis test was performed on simulated nearest percent estimates and Horsfall-Barratt (H-B) scaled data. Both data 
sets were analyzed using a t test and, in addition, the H-B scaled data were analyzed using the Mann-Whitney test. Assumed sample size (n) = 25, mean of 
population A (µA) = 40, difference between populations (µΔ) = 10, and s.d. (ϕ) = 5, with a threshold for rejecting H0 of 0.05. The resulting calculated s.d. data 
based on parameter estimates of 2α/β, α/β, and α/2β were fit to the actual severity (0 to 60%) to demonstrate the effect of changing rater ability on the s.d. of the 
estimate (D, 2α/β, E,  α/β, F, α/2β) across the full spectrum of disease severity in this study (1 to 50%). The bold black line is the original hyperbolic fit of mean
rater s.d., σ = αµactual/β + µactual, where α = 19.08 ( s.d. = 3.19) and β = 29.65 (s.d. = 9.334). 
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population means, population mean differences, and rater ability. 
However, it is pertinent to note that, if population variability is 
large, the effect of the H-B scale will be relatively small compared 
with sample variability, resulting in risk of a type II error being 
similar for analyses based on NPEs or H-B scale data (Fig. 8). 
In this study, we assumed that the NPE was invariably in the 
correct H-B interval. Although raters might not always rate 
severity in the correct interval (10,11,22), this tendency has not 
been characterized; therefore, we describe a “best-case” scenario. 
Thus, estimates of disease severity by an inaccurate rater were not 
improved by taking NPEs compared with the H-B scale because 
the variance of the sample means were large using either method. 
However, raters of average ability using NPEs provided data with 
a higher probability of rejecting H0 when H0 was false. Thus, on 
average, the NPEs of disease, particularly in the mid-range of the 
H-B interval scale, are better than what can be achieved by 
applying a grade or midpoint value. Raters who happen to be 
experienced, particularly accurate, highly trained, or who use 
standard area diagrams to improve the accuracy of each estimate 
(1,5,17,28,29) will provide NPEs that are most often much better 
than can be achieved with H-B scaled data. This might even be so 
at lower disease severities (<20%) because they will, on average, 
provide estimates closer to the actual values compared with H-B 
grades or midpoints in these ranges. Inevitably, in rating disease, 
inappropriate grades are chosen (22). Furthermore, if there is 
consistent bias, the mean value will be less accurate. A remaining 
need is to characterize how raters apply the grade directly, and 
identify the effect of these characteristics on hypothesis testing. 
In all cases, increasing sample size improves the probability of 
rejecting H0 when H0 is false but, as noted above, if the H-B scale 
is used and assuming no bias, up to 50% more samples are 
required to achieve a comparable probability. In defense of 
Horsfall and Barratt (15), they did state the need for substantial 
sample size when using the scale (15,16), and they never 
advocated basing the sample on a single or few estimates within a 
plot, and recommended a minimum of at least 20 individual assess-
ments to achieve an accurate estimate of the mean. Additional 
sampling units cost resources (26,27), and it might be argued that 
taking grade data is much faster than taking NPEs, although this 
has not been demonstrated. 
Hypothesis testing and the H-B scale. Many aspects of plant 
pathology, including comparing the effects of fungicide treat-
ments and studying yield loss; cultural, agronomic, and manage-
ment factors; disease resistance; and development of epidemics, 
rely on hypothesis testing. There are situations where the 
characteristics of the populations being tested and the rater ability 
(especially if sample sizes are inadequate) can increase the risk of 
a type II error when the H-B scale is used relative to NPEs. 
However, it should be noted that NPEs are error prone, too, and 
can result in faulty hypothesis testing (32), although to a lesser 
degree in the situations mentioned above. 
Although the H-B scale can cause elevated type II error, it does 
not appear to influence the rate of type I error situations in 
hypothesis testing based on disease severity assessments. When 
the severity distributions of the two treatments were the same  
(µΔ = 0), the t test rejected the H0 at the same rate for both the  
H-B scale and NPEs. Thus, both assessment methods committed a 
type I error in ≈5% of the cases by rejecting H0 when H0 was true, 
closely agreeing with the choice of a P value of 0.05. In addition, 
these data were run at a P value of 0.1 and the type I error rate 
was 10%, as expected (data not shown), and the relationships 
among all these data tested at 0.05% remained similar when the P 
value of 0.1 was used. Thus, there was no discernible qualitative 
effect of the H-B scale at different P values on the ability to reject 
H0 when H0 was false (Fig. 4). 
Some general comment on hypothesis testing in relation to 
the H-B scale and other nonlinear scales for estimating dis-
ease. Hypothesis testing was based on the t test. The t test is a 
parametric test that makes some basic assumptions about the data, 
including normality, independence between samples, absence of 
outliers, and equal variances in relation to sample size. For this 
reason, a normal distribution of disease severity was assumed. 
There is limited information available on the frequency distri-
bution of severity (percent area infected) on leaves of diseased 
plants (23), although it is known to change with mean disease 
severity and the point in the epidemic (11,21). The frequency 
distribution of diseased leaf severity can affect the accuracy of 
mean estimates using interval scales with different numbers of 
classes (11,20) but it is unlikely that differences in the population 
distributions would change the underlying effects of the H-B scale 
on sample variance that we describe here. Regardless of the 
underlying severity distributions, in experiments where analysis is 
based on several replicates, each being based on a large sample 
size, the central limit theorem states that the distribution of the 
means approximates to normal and, thus, the assumptions of 
parametric analysis are acceptable. 
Other parametric tests make similar assumptions of normality 
and should be used only where interval scales have equal intervals 
on a continuous scale (37). Previous work has demonstrated the 
bias resulting from directly averaging the logarithmically based 
H-B scale data without first converting back to a percent (34). 
However, a nonparametric test is more appropriate for unequal 
interval-sized grade data; therefore, we analyzed the H-B scale 
grade data using the Mann-Whitney U test alongside the t test 
used for the midpoint values and found that the nonparametric 
test had a larger probability of a type II error compared with using 
the H-B scale midpoint percentages or the NPE data. This is to be 
expected because nonparametric tests are generally less powerful 
than parametric tests based on ratio level data. 
Interval scales might be used to obtain data on disease severity 
for several purposes (surveys, hypothesis testing, forecasting, and 
so on). Some suggested modifications to the H-B scale to use for 
estimates of disease at a plot level based on a single sample might 
be too complex (1) to usefully apply in the field, because there are 
too many grades and the potential advantage of speed would be 
lost. Other nonlinear scales used include seven- or eight-category 
intervals with unequal interval sizes (11,20). Other suggestions 
for additional grades in the H-B scale have been made (7,18,25, 
26), and many others scales developed to rate disease (36). Par-
ticularly where disease severity data are to be used for hypothesis 
testing, our results suggest that it is desirable that a scale reflect 
the approximate ability of a rater. A disease scale with 5% 
increments might do this (25,26) although, at low disease severity, 
additional grades would be useful (for example, 0, 0.1, 1.0, 2.5, 
5.0, 7.5, 10.0, 15.0%…) because the human eye appears more 
capable of differentiating disease at low severity (3,5,11,19). 
Furthermore, it can be argued that, for much epidemiological 
work, it is disease at low severity that needs to be most accurately 
estimated because these assessments form the basis for obtaining 
parameters that might be used in projecting epidemic develop-
ment. Simulation modeling can usefully be applied to test and 
compare the use of different scales for disease assessment under 
different scenarios. 
It has not been established how much time can be saved using a 
disease severity scale compared with NPEs. Direct application of 
the H-B scale is practiced (10,31) and incorrect grading of disease 
severity can lead to additional error (22). There is also some 
evidence that direct use of the H-B scale might result in a 
“linearizing” of the log-scale intervals (10), which would lead to 
further bias in the mean value. These tendencies would increase 
error of the mean estimates but they have not been sufficiently 
characterized. In this study, as in some others (2,25), we con-
verted the NPE to the H-B scale, thereby guaranteeing that the 
NPE was graded correctly. 
Conclusion. The logarithmic nature of the H-B scale is 
controversial (2,7,12,18,30,25,38). Based on these data, there are 
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many situations where the two methods are equally good for 
hypothesis testing but the H-B scale was never better than NPEs 
for comparing treatments, and can result in less precise data 
leading to a greater risk of type II error (2,10,25,26). Increasing 
the sample size reduces this risk. However, an NPE has an 
advantage in that “…it allows observed differences to be recorded 
and used” (18). Observed differences are not subject to additional 
error by rescaling, and can be revisited as an honest repre-
sentation of the rater’s assessment of severity which might be 
useful to posterity. 
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